U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth

Kemper

26/12/2024 13:03

Dec 26 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Apple, EverQuote and UnitedHealth on
Thursday. 
    
  HIGHLIGHTS 
           
     * Apple Inc  AAPL.O : Wedbush raises target price to $325 from $300
     * EverQuote Inc  EVER.O : Raymond James raises to strong buy from outperform
     * Progressive Corp  PGR.N : Raymond James raises to outperform from market perform
     * Rapt Therapeutics Inc  RAPT.O : H.C. Wainwright raises to buy from neutral
     * UnitedHealth  UNH.N : Raymond James adds stock to its analyst current favorites list
 
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.
    
     * ACV Auctions Inc  ACVA.O : Needham raises target price to $28 from $26
     * Anavex Life Sciences Corp  AVXL.O : H.C. Wainwright raises target price to $42 from $40
     * Apple Inc  AAPL.O : Wedbush raises target price to $325 from $300
     * EverQuote Inc  EVER.O : Raymond James raises to strong buy from outperform
     * Hagerty Inc  HGTY.N : Raymond James cuts to underperform from market perform
     * Kemper Corp  KMPR.N : Raymond James raises target price to $82 from $75
     * Palvella Therapeutics Inc.  PVLA.O : H.C. Wainwright initiates coverage with buy rating
     * Progressive Corp  PGR.N : Raymond James raises to outperform from market perform
     * Rapt Therapeutics Inc  RAPT.O : H.C. Wainwright raises to buy from neutral
     * Surgery Partners Inc  SGRY.O : Benchmark cuts target price to $40 from $50
     * UnitedHealth  UNH.N : Raymond James adds stock to its analyst current favorites list
  

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))